Home Authors Posts by Dominic Cuthbert

Dominic Cuthbert

49 POSTS 0 COMMENTS
http://www.pbiforum.net
Immusoft and Takeda to develop cell therapies for rare neurometabolic disorders
Featured

Immusoft and Takeda to develop cell therapies for rare neurometabolic disorders

Dominic Cuthbert -
0
CureVac to shift focus of COVID-19 vaccine development to second-gen mRNA tech
Featured

CureVac to shift focus of COVID-19 vaccine development to second-gen mRNA tech

Dominic Cuthbert -
0
Advancing access to complex medicines through Strategic Growth
Featured

Advancing access to complex medicines through Strategic Growth

Dominic Cuthbert -
0
Acquisition sees Supernus strengthen CNS product portfolio
Featured

Acquisition sees Supernus strengthen CNS product portfolio

Dominic Cuthbert -
0
Pacira BioSciences boosts non-opioid pain management position with Flexion acquisition
Featured

Pacira BioSciences boosts non-opioid pain management position with Flexion acquisition

Dominic Cuthbert -
0
Ipsen taps Novartis talent for new Specialty Care International president
Appointments

Ipsen taps Novartis talent for new Specialty Care International president

Dominic Cuthbert -
0
Merck submits EUA in the US for molnupiravir
APPROVALS

Merck submits EUA in the US for molnupiravir

Dominic Cuthbert -
0
Sandoz completes acquisition of GSK’s cephalosporin antibiotics business
Featured

Sandoz completes acquisition of GSK’s cephalosporin antibiotics business

Dominic Cuthbert -
0
Humanigen signs contract with Clinigen for Lenzilumab Managed Access Program in Europe
Featured

Humanigen signs contract with Clinigen for Lenzilumab Managed Access Program in Europe

Dominic Cuthbert -
0
Entia rases £12m to launch virtual oncology solution
Featured

Entia rases £12m to launch virtual oncology solution

Dominic Cuthbert -
0
123...5Page 1 of 5

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks